Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic and pharmacokinetic study of strong-acting opioids for cancer-related pain
NL-OMON29058Recruiting
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Jan 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer pain, sponsored by Erasmus MC Cancer Institute. Primary endpoints: Association of pharmacogenetic and pharmacokinetic variation with pain control and side effects, Role of demographic and clinical factors and 1 more. Started Jan 2010; status: recruiting.
02
Conditions
cancer pain
Beyond the preview
Go deeper on NL-OMON29058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29058.